MedPath

Efficacy of Dry Needling Treatment in Myofascial Pain Syndrome

Not Applicable
Completed
Conditions
Trigger Point Pain, Myofascial
Interventions
Procedure: dry-needling
Registration Number
NCT05066529
Lead Sponsor
Kanuni Sultan Suleyman Training and Research Hospital
Brief Summary

The aim of this study is to investigate the short and long-term effects of dry-needling of participants with trigger points in the upper trapezius muscle.

64 participants who diagnosed with myofascial pain syndrome will be included in the study. All participants will have trigger points in the upper trapezius muscles. They are randomised into two groups: dry needling (n=32) and exercise group (n=32). Ultrasonographic evaluation of trigger points (diameter, circumference and area), pain intensity and neck disability will be evaluated as primary outcome. Active cervical range of motion will be evaluated as secondary outcome.

Detailed Description

Objective: The aim of this study is to investigate the short and long-term effects of dry-needling of participants with trigger points in the upper trapezius muscle.

Methods: 64 participants who diagnosed with myofascial pain syndrome will be included in the study. All participants will have trigger points in the upper trapezius muscles. They are randomised into two groups: dry needling (n=32) and exercise group (n=32). Ultrasonographic evaluation of trigger points (diameter, circumference and area), pain intensity and neck disability will be evaluated as primary outcome. Active cervical range of motion will be evaluated as secondary outcome.

All treatments will be applied by an investigator and a different blinded investigator will evaluated all participants. Numerical Rating Scale will be used for evaluating pain intensity and Neck Disability Index will be used for evaluating neck disability.

Dry-needling treatment will be applied once a week for three weeks. Servical stretching exercises are given to all participants. (20 repetitions in one session and 2 sessions in a day, three days a week.)

All participants will be evaluated before treatment, after treatment (at 3rd week) and at 3 month follow-ups.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
62
Inclusion Criteria
  • trigger points in the upper trapezius muscle
  • 18-45 years old
  • no treatment in three months for myofascial pain syndrome (MPS)
  • accept to participate treatment program
Read More
Exclusion Criteria
  • already treated in 3 months for MPS
  • below 18 years and above 45 years old
  • no acceptance to participate the trial
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
dry-needling groupdry-needling32 participants in this group Dry-needling treatment will be applied once a week for three weeks. Servical stretching exercises are given to all participants. (20 repetitions in one session and 2 sessions in a day, three days a week.) All participants will be evaluated before treatment, after treatment (at 3rd week) and at 3 month follow-ups.
exercise groupdry-needling32 participants in this group Servical stretching exercises are given to all participants. (20 repetitions in one session and 2 sessions in a day, three days a week.) All participants will be evaluated before treatment, after treatment (at 3rd week) and at 3 month follow-ups.
Primary Outcome Measures
NameTimeMethod
Neck Disability index3 month follow-ups

a questionnaire to evaluate neck disability

area of trigger point3 month follow-ups

an ultrasonographic evaluation

Numerical Rating Scale3 month follow-ups

a questionnaire to evaluate pain intensity

diameter of trigger point3 month follow-ups

an ultrasonographic evaluation

circumference of trigger point3 month follow-ups

an ultrasonographic evaluation

Secondary Outcome Measures
NameTimeMethod
active servical range of motion3 month follow-ups

active servical range of motion

Trial Locations

Locations (1)

Kanuni Sultan Suleyman Training and Research Hospital

🇹🇷

Istanbul, Turkey

© Copyright 2025. All Rights Reserved by MedPath